StockTipsArenaBeta

Wockhardt Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,877.2-29.10 (-1.53%)
As of 21 Oct 2026

Avg 1-year target

All 2 long-term calls are BUY

₹2,95057.1% above today's price

Wockhardt's average 1-year share price target is ₹2,950, the average of 2 advisors' latest targets. Targets range from ₹2,400 to ₹3,500.

Latest: Vaishali Parekh, Prabhudas Lilladher ₹2,400 · 29 Jul 2026

2
2 BUY · 0 SELL, all horizons
2
with an active 1Y target
18%
3 of 17 closed calls hit
20
all horizons, open and closed
Watch WOCKPHARMA for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Wockhardt target price by brokerage

Each advisor's latest 1-year target · 2 advisors · tap a row for the call

All tips (20)

BUYTarget₹2,400
VPbyVaishali Parekh, Prabhudas Lilladher+27.8% to target
1 Year* · 9 mo left · 29 Jul 2026 · entry ₹1,922.8 · via NDTV ProfitP&L -2.4%
BUYTarget₹3,500
SCbyShrikant Chouhan, Kotak Securities+86.4% to target
1 Year* · 7 mo left · 1 Jun 2026 · entry ₹2,230.3 · via NDTV ProfitP&L -15.8%
BUYTarget₹1,870
ASbyAxis SecuritiesTarget hit
1 Year* · 8 Jul 2025 · entry ₹1,657.8 · via Institutional / Brokerage Researchexit ₹1,870
BUYTarget₹2,400
SMbySomil Mehta, SharekhanStop-loss hit
1–3 Months · 4 Sept 2026 · entry ₹2,085 · via CNBC Awaaz.exit ₹1,970
BUYTarget₹2,110
ICbyIDBI CapitalStop-loss hit
1–3 Months* · 27 Aug 2026 · entry ₹1,945 · via IDBI Capital Research Calls Telegramexit ₹1,875
BUYTarget₹2,100
GSbyGaurav Sharma, Globe Capital MarketTarget hit
1–2 Weeks* · 11 Jun 2026 · entry ₹1,932 · via CNBC Awaaz.exit ₹2,100
BUYTarget₹1,700
CTbyChandan Taparia, Motilal OswalTarget hit
1–2 Weeks* · 20 May 2026 · entry ₹1,617.6 · via NDTV Profitexit ₹1,700
BUYTarget₹2,400
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 9 Sept 2026 · entry ₹2,240 · via IDBI Capital Research Calls Telegramexit ₹2,165
BUYTarget₹2,300
NJbyNilesh Jain, Centrum BrokingStop-loss hit
1–2 Weeks* · 7 Sept 2026 · entry ₹2,207 · via NDTV Profitexit ₹2,100
BUYTarget₹2,090
SRbySiddharth Rai MangalaStop-loss hit
1–2 Weeks* · 28 Aug 2026 · entry ₹1,976.1 · via Zee Business (Live)exit ₹1,915
BUYTarget₹2,200
MKbyMehul Kothari, Anand RathiStop-loss hit
1–2 Weeks* · 10 Aug 2026 · entry ₹2,037 · via Zee Business (Live)exit ₹1,950
BUYTarget₹2,250
SMbySomil Mehta, SharekhanStop-loss hit
1–2 Weeks* · 7 Aug 2026 · entry ₹2,007.5 · via CNBC Awaaz.exit ₹1,960
BUYTarget₹2,165
KBbyKush BohraStop-loss hit
1–2 Weeks* · 4 Aug 2026 · entry ₹2,028.4 · via NDTV Profit (Live)exit ₹1,965
BUYTarget₹2,160
MKbyMehul Kothari, Anand RathiStop-loss hit
1–2 Weeks* · 3 Aug 2026 · entry ₹1,978 · via Zee Business (Live)exit ₹1,860
BUYTarget₹2,350
KBbyKunal BothraExpired
1–2 Weeks* · 6 Oct 2026 · entry ₹2,163 · via ET Nowexit ₹1,901.5
BUYTarget₹2,400
DMbyDeven Mehata, IDBI Capital Markets and SecuritiesExpired
1–2 Weeks · 23 Sept 2026 · entry ₹2,220 · via NDTV Profitexit ₹2,151.6
BUYTarget₹2,300
CTbyChandan Taparia, Motilal OswalExpired
1–2 Weeks* · 7 Sept 2026 · entry ₹2,000 · via ET Now (Live)exit ₹2,186
BUYTarget₹2,323
SJbySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesExpired
1–2 Weeks* · 28 Aug 2026 · entry ₹1,962 · via NDTV Profit (Live)exit ₹2,219.6
BUYTarget₹1,750
KBbyKunal Bothra○ No trade
1–2 Weeks* · 26 May 2026 · entry ₹1,700 · via ET Now
BUYTarget₹1,815
ABbyArpit Beriwal, Motilal OswalExpired
1–2 Weeks* · 7 May 2026 · entry ₹1,650 · via ET Nowexit ₹1,600

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks